Content reflects the views of the posting party and is provided for informational purposes only. It does not constitute a solicitation, recommendation, endorsement, or investment advice by BioTech Funding Portal.  All content is subject to the portal’s Community Content Guidelines.

 

 

Brian Christie

Co-Founder

BioTech Social Inc.

Entrepreneur and inventor operating at the intersection of technology, finance, and regulation. View (0) Answers

Karin Hellsvik

Vice President, Head of IR & Comms; Strategic Advisor

Foghorn Therapeutics

Executive with 20+ years of experience and passion for improving patient care; building long-term value for biotech investors View (0) Answers

Chris Hopkins

CEO

Glafabra Therapeutics

Developing durable cell-based gene therapies for Fabry, Gaucher, Pompe & other enzyme deficiencies. View (0) Answers

Robert Barich

Managing Director

CNR Search

25+ years in executive search, life sciences investing, and company-building to match leaders with business needs. View (0) Answers

Tetsu Yung

Director of JAPAC Strategy

Glafabra Therapeutics

Building JAPAC strategy for Glafabra to advance durable, cell-based therapy for Fabry disease patients View (0) Answers

Brian Freeman

CEO & Co-Founder

Energesis Pharmaceuticals

Entrepreneur & physician with deep experience in obesity and a drive to help provide better solutions for patients View (0) Answers

Eydith Comenencia Ortiz

Founder

CONECTA

Executive with 15 years of experience advancing biotech innovation with evidence-based patient engagement & insights generation View (0) Answers

Want to see more? Login or Register for Free.